Search

Show 37696 results
Displaying 451–460 of 37696 results.
  • Educational Program

    … Core Curriculum The Urology Service complements the clinical training and research opportunities available to fellows with a formal educational program, including multidisciplinary genitourinary oncology grand rounds, a disease-specific didactic lecture series, an indications and interesting cases conference

  • Video
    Meet Eli Diamond: Neuro-Oncologist at MSK

    Dr. Eli Diamond cares for people with brain tumors and rare blood cancers like histiocytosis at MSK, leading research and trials that provide access to new therapies.

    … Dr. Eli Diamond cares for people with brain tumors and rare blood cancers like histiocytosis at MSK, leading research and trials that provide access to new therapies. Hi, I’m Dr. Eli Diamond, a neuro-oncologist at Memorial Sloan Kettering Cancer Center. I’m an expert and researcher in histiocytosis,

  • The Britta Weigelt Lab
    Clarissa Lam

    … Job Title GYN Oncology Fellow Education B.S. Biology, St. John’s University; M.D. New York University School of Medicine Degree MD Start Year 2022

  • Clinical Trial
    A Phase 1 Study of AJ1-11095 in People With Myelofibrosis

    … Full Title A Multicenter, Open-Label, Phase 1 Study of AJ1-11095 Administered as Oral Monotherapy in Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i

  • News
    Putting the STING in Immunotherapy: Research Focuses on Ways to Improve Cancer Treatments

    Researchers are looking for ways to make cancer cells more visible to the immune system.

    … Wednesday, September 19, 2018 Summary Researchers are looking for ways to make checkpoint inhibitor drugs more effective. One tactic is by making cancer cells more visible to the immune system. Drugs called immune checkpoint inhibitors have made a significant difference for some people with cancer. They

  • Technology Development
    Primary Tumor Suppression by Antisense Delivery via Homing Peptide

    … SK1334 Summary of Invention Memorial Sloan Kettering scientists have successfully suppressed primary tumor growth in animal models of breast cancer. They accomplished this by targeting the Id1 transcription factor, a target for anti-angiogenic tumor therapy. The proteins belonging to the Id family are

  • Clinical Trial
    A Phase 2 Study of Belumosudil in People With Chronic Graft vs. Host Disease

    … Full Title Randomized Phase II study of belumosudil vs. placebo for preemptive treatment of chronic graft vs. host disease Purpose After a stem cell transplant, a condition called chronic graft-versus-host disease (cGVHD) can occur. The new donor immune cells (like T cells and B cells) attack the recipient

  • Lynn A. Brody
    Interventional Radiologist
    Lynn A. Brody

    I am an interventional radiologist who uses state-of-the-art radiology imaging equipment (such as CT, ultrasound, MRI, and real-time x-rays, called fluoroscopy) to guide minimally invasive procedures, which require only tiny incisions.

    … Interventional Radiologist Job Title Attending Radiologist I am an interventional radiologist who uses state-of-the-art radiology imaging equipment (such as CT, ultrasound, MRI, and real-time x-rays, called fluoroscopy) to guide minimally invasive procedures, which require only tiny incisions. Read more

  • Lynn A. Brody
    Interventional Radiologist
    Lynn A. Brody

    Soy una radióloga intervencionista que cuenta con equipos de imagenología de radiología de última generación (como tomografía computarizada, ultrasonido, resonancia magnética y rayos X en tiempo real, llamados fluoroscopia) para guiar procedimientos de invasión mínima, que solo requieren incisiones pequeñas.

    … Interventional Radiologist Job Title Radiólogo adjunto Soy una radióloga intervencionista que cuenta con equipos de imagenología de radiología de última generación (como tomografía computarizada, ultrasonido, resonancia magnética y rayos X en tiempo real, llamados fluoroscopia) para guiar procedimientos

  • News
    Michael Foley Named Director of Tri-Institutional Therapeutics Discovery Institute

    A renowned chemist with 25 years of industry and academic experience, Michael Foley will lead a pioneering collaboration designed to speed the development of new drugs for people with cancer and other diseases.

    … Thursday, December 5, 2013 Summary A renowned chemist with 25 years of industry and academic experience, Michael Foley will lead a pioneering collaboration designed to speed the development of new drugs for people with cancer and other diseases. Michael A. Foley, a renowned chemist and entrepreneur,